title: Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of Oncology.
authors.forename: S R
authors.initials: SR
authors.lastname: Riddell
authors.forename: P D
authors.initials: PD
authors.lastname: Greenberg
authors.forename: R W
authors.initials: RW
authors.lastname: Overell
authors.forename: T P
authors.initials: TP
authors.lastname: Loughran
authors.forename: M J
authors.initials: MJ
authors.lastname: Gilbert
authors.forename: S D
authors.initials: SD
authors.lastname: Lupton
authors.forename: J
authors.initials: J
authors.lastname: Agosti
authors.forename: S
authors.initials: S
authors.lastname: Scheeler
authors.forename: R W
authors.initials: RW
authors.lastname: Coombs
authors.forename: L
authors.initials: L
authors.lastname: Corey
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D016827:CD8 Antigens; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D006679:HIV Seropositivity / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D016219:Immunotherapy, Adoptive; D016483:Lymphoma, AIDS-Related / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D008875:Middle Aged; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000637:transplantation*; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D016827:CD8 Antigens; D015215:Zidovudine